The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
The risks of long-term use of proton pump inhibitors: a critical review
Open accessAbstract
Proton pump inhibitors (PPIs) are among the most frequently prescribed medications. Their use is likely even higher than estimated due to an increase in the number of PPIs available without a prescription. Appropriate indications for PPI use include Helicobacter pylori infection, erosive esophagitis, gastric ulcers, and stress ulcer prevention in high-risk critically ill patients. Unfortunately, PPIs are often used off-label for extended periods of time. This increase in PPI usage over the past two decades has called into question the long-term effects of these medications. The association between PPI use and infection, particularly Clostridium difficile and pneumonia, has been the subject of several studies. It’s proposed that the alteration in gastrointestinal microflora by PPIs produces an environment conducive to development of these types of infections. At least one study has suggested that long-term PPI use increases the risk of dementia. Drug interactions are an important and often overlooked consideration when prescribing any medication. The potential interaction between PPIs and antiplatelet agents has been the subject of multiple studies. One of the more recent concerns with PPI use is their role in the development or progression of chronic kidney disease. There is also some literature suggesting that PPIs contribute to the development of various micronutrient deficiencies. Most of the literature examining the potential adverse effects of PPI use is composed of retrospective, observation studies. There is a need for higher quality studies exploring this relationship.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Clopidogrel with or without Omeprazole in Coronary Artery Disease
Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007964 · Cited by 1,240
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
Gilard, M., Arnaud, B., Cornily, J.-C., Le Gal, G., Lacut, K., Le Calvez, G., Mansourati, J., Mottier, D., Abgrall, J.-F., & Boschat, J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.064 · Cited by 1,015
Ho, P. M. (2009) · JAMA · doi:10.1001/jama.2009.261 · Cited by 1,007
Freedberg, D. E., Kim, L. S., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 891
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
Juurlink, D. N., Gomes, T., Ko, D. T., Szmitko, P. E., Austin, P. C., Tu, J. V., Henry, D. A., Kopp, A., & Mamdani, M. M. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.082001 · Cited by 766
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Lazarus, B., Chen, Y., Wilson, F. P., Sang, Y., Chang, A. R., Coresh, J., & Grams, M. E. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7193 · Cited by 729
The Burden of Gastrointestinal and Liver Diseases, 2006
Shaheen, N. J., Hansen, R. A., Morgan, D. R., Gangarosa, L. M., Ringel, Y., Thiny, M. T., Russo, M. W., & Sandler, R. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00723.x · Cited by 691
Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis
Kwok, C. S., Arthur, A. K., Anibueze, C. I., Singh, S., Cavallazzi, R., & Loke, Y. K. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.108 · Cited by 581
Gomm, W., von Holt, K., Thomé, F., Broich, K., Maier, W., Fink, A., Doblhammer, G., & Haenisch, B. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4791 · Cited by 563
Acid-suppressive medication use and the risk for hospital-acquired pneumonia
Herzig, S. J. (2009) · JAMA · doi:10.1001/jama.2009.722 · Cited by 486
Complications of Proton Pump Inhibitor Therapy
Vaezi, M. F., Yang, Y.-X., & Howden, C. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.047 · Cited by 482
Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD
Xie, Y., Bowe, B., Li, T., Xian, H., Balasubramanian, S., & Al-Aly, Z. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121377 · Cited by 337
Lambert, A. A., Lam, J. O., Paik, J. J., Ugarte-Gil, C., Drummond, M. B., & Crowell, T. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128004 · Cited by 327
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
Linsky, A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.73 · Cited by 276
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal
Savarino, V., Dulbecco, P., de Bortoli, N., Ottonello, A., & Savarino, E. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.10.007 · Cited by 270
Risk of dementia in elderly patients with the use of proton pump inhibitors
Haenisch, B., von Holt, K., Wiese, B., Prokein, J., Lange, C., Ernst, A., Brettschneider, C., König, H.-H., Werle, J., Weyerer, S., et al. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0554-0 · Cited by 244
MacLaren, R., Reynolds, P. M., & Allen, R. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.14673 · Cited by 238
Xie, Y., Bowe, B., Li, T., Xian, H., Yan, Y., & Al-Aly, Z. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015735 · Cited by 234
Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors: A Cohort Study
Ray, W. A., Murray, K. T., Griffin, M. R., Chung, C. P., Smalley, W. E., Hall, K., Daugherty, J. R., Kaltenbach, L. A., & Stein, C. M. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-6-201003160-00003 · Cited by 230
Overuse of acid-suppressive therapy in hospitalized patients1
Nardino, R. J., Vender, R. J., & Herbert, P. N. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03259.x · Cited by 221
McDonald, E. G., Milligan, J., Frenette, C., & Lee, T. C. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.42 · Cited by 216
Cheungpasitporn, W., Thongprayoon, C., Kittanamongkolchai, W., Srivali, N., Edmonds, P. J., Ungprasert, P., O'Corragain, O. A., Korpaisarn, S., & Erickson, S. B. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1057800 · Cited by 215
Deshpande, A., Pant, C., Pasupuleti, V., Rolston, D. D. K., Jain, A., Deshpande, N., Thota, P., Sferra, T. J., & Hernandez, A. V. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.09.030 · Cited by 213
Inappropriate prescribing of proton pump inhibitors in primary care
Batuwitage, B. T., Kingham, J. G. C., Morgan, N. E., & Bartlett, R. L. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.051151 · Cited by 206
Xie, Y., Bowe, B., Li, T., Xian, H., Yan, Y., & Al-Aly, Z. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.021 · Cited by 202
A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors
Clooney, A. G., Bernstein, C. N., Leslie, W. D., Vagianos, K., Sargent, M., Laserna‐Mendieta, E. J., Claesson, M. J., & Targownik, L. E. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13568 · Cited by 166
Seto, C. T., Jeraldo, P., Orenstein, R., Chia, N., & DiBaise, J. K. (2014) · Microbiome · doi:10.1186/2049-2618-2-42 · Cited by 163
Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease
Klatte, D. C. F., Gasparini, A., Xu, H., de Deco, P., Trevisan, M., Johansson, A. L. V., Wettermark, B., Ärnlöv, J., Janmaat, C. J., Lindholm, B., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.046 · Cited by 163
Alshamsi, F. E., Belley‐Côté, E. P., Cook, D., Almenawer, S. A., Alqahtani, Z., Perri, D., Thabane, L., Al‐Omari, A., Lewis, K. A., Guyatt, G. H., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1305-6 · Cited by 158
Park, C. H., Kim, E. H., Roh, Y. H., Kim, H. Y., & Lee, S. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112558 · Cited by 153
Proton Pump Inhibitors and Hypomagnesemia in the General Population: A Population-Based Cohort Study
Kieboom, B. C. T., Jong, J. C. K., Eijgelsheim, M., Franco, O. H., Kuipers, E. J., Albert Hofman, D., Zietse, R., Stricker, B. H. C., & Hoorn, E. J. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.05.012 · Cited by 147
Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
Arora, P., Gupta, A., Golzy, M., Patel, N., Carter, R. L., Jalal, K., & Lohr, J. W. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0325-4 · Cited by 125
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients
Freedberg, D. E., Salmasian, H., Friedman, C., & Abrams, J. A. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.333 · Cited by 116
Proton pump inhibitors as a risk factor for recurrence ofClostridium-difficile-associated diarrhea
Kim, J. W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i28.3573 · Cited by 110
Association of proton-pump inhibitors with outcomes inClostridium difficilecolitis
Cadle, R. M., Mansouri, M. D., Logan, N. D., Kudva, D. R., & Musher, D. M. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060629 · Cited by 101
Barletta, J. F., & Sclar, D. A. (2014) · Critical Care · doi:10.1186/s13054-014-0714-7 · Cited by 91
Are proton pump inhibitors really so dangerous?
Savarino, V., Dulbecco, P., & Savarino, E. V. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.05.018 · Cited by 87
Arriola, V., Tischendorf, J. S., Musuuza, J., Barker, A., Rozelle, J. W., & Safdar, N. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.194 · Cited by 85
Bateman, B. T., Bykov, K., Choudhry, N. K., Schneeweiß, S., Gagne, J. J., Polinski, J. M., Franklin, J. M., Doherty, M., Fischer, M., & Rassen, J. A. (2013) · BMJ · doi:10.1136/bmj.f5416 · Cited by 82
Overuse of acid-suppressive therapy in hospitalized patients
Nardino, R. J. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02052-9 · Cited by 71
Stevens, V. W., Dumyati, G. K., Brown, J. E., & van Wijngaarden, E. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2198 · Cited by 67
Wijarnpreecha, K., Thongprayoon, C., Chesdachai, S., Panjawatanana, P., Ungprasert, P., & Cheungpasitporn, W. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4725-5 · Cited by 67
Long-Term PPI Use: Balancing Potential Harms and Documented Benefits
Laine, L., & Nagar, A. B. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.156 · Cited by 54
Niu, Q., Wang, Z., Zhang, Y., Wang, J., Zhang, P., Wang, C., Yin, X., & Hou, Y. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416663647 · Cited by 48
Roughead, E. E., Chan, E. W., Choi, N., Griffiths, J., Jin, X.-M., Lee, J., Kimura, M., Kimura, T., Kubota, K., Lai, E. C., et al. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1238071 · Cited by 45
Ro, Y., Eun, C. S., Kim, H. S., Kim, J. Y., Byun, Y. J., Yoo, K.-S., & Han, D. S. (2016) · Gut and Liver · doi:10.5009/gnl15324 · Cited by 43
Gordon, D., Young, L. R., Reddy, S., Bergman, C., & Young, J. D. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.10.009 · Cited by 42
Arai, N., Nakamizo, T., Ihara, H., Koide, T., Nakamura, A., Tabuse, M., & Miyazaki, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169300 · Cited by 37
Off-Label Use of Gastrointestinal Medications in the Intensive Care Unit
Barletta, J. F., Lat, I., Micek, S. T., Cohen, H., Olsen, K. M., Haas, C. E., & Critical Care Pharmacotherapy Trials Network (2013) · Journal of Intensive Care Medicine · doi:10.1177/0885066613516574 · Cited by 25
Lupșe, M. S., Flonta, M., Cioară, A., Filipescu, I., & Todor, N. (2013) · PubMed · Cited by 21
The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
Li, T., Xie, Y., & Al‐Aly, Z. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000406 · Cited by 19
Li, R., Khatibi, N. H., Qin, X., & Zhang, J. H. (2011) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-7091-0693-8_75 · Cited by 17
Momosaki, R., Yasunaga, H., Matsui, H., Fushimi, K., & Abo, M. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.01.018 · Cited by 17
dos Santos, O., Boisset, S., Seigneurin, A., & Épaulard, O. (2016) · SpringerPlus · doi:10.1186/s40064-016-2058-z · Cited by 17
Cited by
Berger, M. M., Shenkin, A., Schweinlin, A., Amrein, K., Augsburger, M., Biesalski, H.-K., Bischoff, S. C., Casaer, M. P., Gundogan, K., Lepp, H.-L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.02.015 · Cited by 615
Lima, J. J., Thomas, C. D., Barbarino, J., Desta, Z., Van Driest, S. L., El Rouby, N., Johnson, J. A., Cavallari, L. H., Shakhnovich, V., Thacker, D. L., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2015 · Cited by 315
Metadata
- Authors
- Jaynes, M., & Kumar, A. B.
- Venue
- Therapeutic Advances in Drug Safety
- Publisher
- SAGE Publications
- Published
- 2018-11-19
- Volume
- 10
- Pages
- 2042098618809927-2042098618809927
- ISSN
- 2042-0986 (ISSN-L)
- 2042-0994
- OpenAlex
- W2900861028
- Cited by
- 254
- References
- 56
- Type
- conference abstract
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.